Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Protein profiling of infected human gastric epithelial cells with an Iranian Helicobacter pylori clinical isolate.

Fazeli Z, Alebouyeh M, Mansouri V, Malekpour H.

Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S139-S145.

2.

Relationships of H. pylori infection and its related gastroduodenal morbidity with metabolic syndrome: a large cross-sectional study.

Refaeli R, Chodick G, Haj S, Goren S, Shalev V, Muhsen K.

Sci Rep. 2018 Mar 6;8(1):4088. doi: 10.1038/s41598-018-22198-9.

3.

Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2/TIS21 via downregulating cytoplasmic nucleolin expression.

Devanand P, Oya Y, Sundaramoorthy S, Song KY, Watanabe T, Kobayashi Y, Shimizu Y, Hong SA, Suganuma M, Lim IK.

Exp Mol Med. 2018 Feb 23;50(2):e449. doi: 10.1038/emm.2017.281.

4.

Gut microbiome: a new player in gastrointestinal disease.

Gorkiewicz G, Moschen A.

Virchows Arch. 2018 Jan;472(1):159-172. doi: 10.1007/s00428-017-2277-x. Epub 2017 Dec 14. Review.

5.

Evaluating the relationship between serum immunoglobulin G (IgG) and A (IgA) anti-CagA antibody and the cagA gene in patients with dyspepsia.

Fakhre-Yaseri H, Baradaran-Moghaddam A, Shekaraby M, Baradaran HR, Soltani-Arabshahi SK.

Iran J Microbiol. 2017 Apr;9(2):97-102.

6.

Comparison of lipopolysaccharides composition of two different strains of Helicobacter pylori.

Leker K, Lozano-Pope I, Bandyopadhyay K, Choudhury BP, Obonyo M.

BMC Microbiol. 2017 Dec 4;17(1):226. doi: 10.1186/s12866-017-1135-y.

7.

Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studies.

Park AM, Omura S, Fujita M, Sato F, Tsunoda I.

Clin Exp Neuroimmunol. 2017 Aug;8(3):215-232. doi: 10.1111/cen3.12401. Epub 2017 Jul 23.

PMID:
29158778
8.
9.

Genetic Variations and Gastric Cancer Risk.

Marcos-Pinto R.

GE Port J Gastroenterol. 2015 Jul 3;22(4):135-136. doi: 10.1016/j.jpge.2015.05.006. eCollection 2015 Jul-Aug. No abstract available.

10.

Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study.

Haj S, Chodick G, Refaeli R, Goren S, Shalev V, Muhsen K.

PLoS One. 2017 Aug 29;12(8):e0183687. doi: 10.1371/journal.pone.0183687. eCollection 2017.

11.

Aminophosphinates against Helicobacter pylori ureolysis-Biochemical and whole-cell inhibition characteristics.

Macegoniuk K, Grela E, Biernat M, Psurski M, Gościniak G, Dziełak A, Mucha A, Wietrzyk J, Berlicki Ł, Grabowiecka A.

PLoS One. 2017 Aug 9;12(8):e0182437. doi: 10.1371/journal.pone.0182437. eCollection 2017.

12.

Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA.

Link A, Langner C, Schirrmeister W, Habendorf W, Weigt J, Venerito M, Tammer I, Schlüter D, Schlaermann P, Meyer TF, Wex T, Malfertheiner P.

World J Gastroenterol. 2017 Jul 14;23(26):4712-4723. doi: 10.3748/wjg.v23.i26.4712.

13.

Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection.

Debowski AW, Walton SM, Chua EG, Tay AC, Liao T, Lamichhane B, Himbeck R, Stubbs KA, Marshall BJ, Fulurija A, Benghezal M.

PLoS Pathog. 2017 Jun 23;13(6):e1006464. doi: 10.1371/journal.ppat.1006464. eCollection 2017 Jun.

14.

Comparative Genomics and Transcriptional Analysis of Flavobacterium columnare Strain ATCC 49512.

Tekedar HC, Karsi A, Reddy JS, Nho SW, Kalindamar S, Lawrence ML.

Front Microbiol. 2017 Apr 19;8:588. doi: 10.3389/fmicb.2017.00588. eCollection 2017.

15.

Erratum to effects of curcumin on Helicobacter pylori infection.

[No authors listed]

Ann Transl Med. 2017 Mar;5(6):153. doi: 10.21037/atm.2017.03.13.

16.

Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies.

Pirini F, Noazin S, Jahuira-Arias MH, Rodriguez-Torres S, Friess L, Michailidi C, Cok J, Combe J, Vargas G, Prado W, Soudry E, Pérez J, Yudin T, Mancinelli A, Unger H, Ili-Gangas C, Brebi-Mieville P, Berg DE, Hayashi M, Sidransky D, Gilman RH, Guerrero-Preston R.

Oncotarget. 2017 Jun 13;8(24):38501-38516. doi: 10.18632/oncotarget.16258.

17.

Helicobacter pylori Induced Phosphatidylinositol-3-OH Kinase/mTOR Activation Increases Hypoxia Inducible Factor-1α to Promote Loss of Cyclin D1 and G0/G1 Cell Cycle Arrest in Human Gastric Cells.

Canales J, Valenzuela M, Bravo J, Cerda-Opazo P, Jorquera C, Toledo H, Bravo D, Quest AF.

Front Cell Infect Microbiol. 2017 Mar 28;7:92. doi: 10.3389/fcimb.2017.00092. eCollection 2017.

18.

From inflammation to gastric cancer: Role of Helicobacter pylori.

Zhang XY, Zhang PY, Aboul-Soud MA.

Oncol Lett. 2017 Feb;13(2):543-548. doi: 10.3892/ol.2016.5506. Epub 2016 Dec 15.

19.

Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis.

Kalisperati P, Spanou E, Pateras IS, Korkolopoulou P, Varvarigou A, Karavokyros I, Gorgoulis VG, Vlachoyiannopoulos PG, Sougioultzis S.

Front Genet. 2017 Feb 27;8:20. doi: 10.3389/fgene.2017.00020. eCollection 2017. Review.

20.

Effects of curcumin on Helicobacter pylori infection.

Vetvicka V, Vetvickova J, Fernandez-Botran R.

Ann Transl Med. 2016 Dec;4(24):479. doi: 10.21037/atm.2016.12.52. Erratum in: Ann Transl Med. 2017 Mar;5(6):153.

Supplemental Content

Support Center